Conform Pharm Overview
- Year Founded
-
2007
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
Conform Pharm General Information
Description
Developer of high-end complex generic drugs designed to treat a variety of diseases. The company's drugs leverage nano-preparation technology to create a number of generic drugs and improved new drugs under research in the oral, transdermal, injection and injection slow-controlled release applications of insoluble drugs, which mainly focuses on the fields of infantile hemangioma, vascular skin diseases, percutaneous superficial analgesia, and injection sustained and controlled release analgesia, enabling the healthcare industry to better treat diseases across varying types and seriousness.
Contact Information
Website
www.whkfxy.comCorporate Office
- C016, Building B4, Building B4-B8, Wuhan National Bioindustry Base
- No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
- Wuhan, Hubei 430074
- China
Corporate Office
- C016, Building B4, Building B4-B8, Wuhan National Bioindustry Base
- No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
- Wuhan, Hubei 430074
- China
Conform Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Conform Pharm Patents
Conform Pharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4026565-A1 | Transdermal penetration enhancing composition and application thereof in timolol preparation | Active | 04-Sep-2019 | ||
| EP-4026565-A4 | Transdermal penetration enhancing composition and application thereof in timolol preparation | Active | 04-Sep-2019 | ||
| EP-4026565-B1 | Transdermal penetration enhancing composition and application thereof in timolol preparation | Active | 04-Sep-2019 | ||
| EP-4026565-C0 | Transdermal penetration enhancing composition and application thereof in timolol preparation | Active | 04-Sep-2019 | ||
| GB-2600633-A | Transdermal penetration enhancing composition and application thereof in timolol preparation | Active | 04-Sep-2019 | A61K31/5377 |
Conform Pharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Conform Pharm FAQs
-
When was Conform Pharm founded?
Conform Pharm was founded in 2007.
-
Where is Conform Pharm headquartered?
Conform Pharm is headquartered in Wuhan, China.
-
What industry is Conform Pharm in?
Conform Pharm’s primary industry is Pharmaceuticals.
-
Is Conform Pharm a private or public company?
Conform Pharm is a Private company.
-
What is Conform Pharm’s current revenue?
The current revenue for Conform Pharm is .
-
Who are Conform Pharm’s investors?
Optics Valley Financial Holdings Group, THG Ventures, Billionhome, Sunz Fund, and Tibet Dorui Pharmaceutical are 5 of 11 investors who have invested in Conform Pharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process